Infex Therapeutics
Alderley Park, GB Β· 1 known investors
Infex Therapeutics (InfexTx) acquires, develops, and licenses drugs to treat drug-resistant and pandemic infectious diseases, advancing a pipeline of anti-infective therapies through clinical trials for patients with life-threatening infections. Based at Alderley Park in North West England, its programs include RESP-X and MET-X targeting critical-priority pathogens.
BiotechHealthtech
Investors Β· 1
Frequently asked questions
- What does Infex Therapeutics do?
- Infex Therapeutics (InfexTx) acquires, develops, and licenses drugs to treat drug-resistant and pandemic infectious diseases, advancing a pipeline of anti-infective therapies through clinical trials for patients with life-threatening infections. Based at Alderley Park in North West England, its programs include RESP-X and MET-X targeting critical-priority pathogens.
- Who are Infex Therapeutics's investors?
- Infex Therapeutics's investors include Perscitus LLP.
- Where is Infex Therapeutics headquartered?
- Infex Therapeutics is headquartered in Alderley Park, GB.